Vaginal misoprostol administration for cervical ripening and labor induction

Clinical Obstetrics and Gynecology

Volumn 49, Issue 3, 2006, Pages 627-641

  Wing, Deborah A ^a,b   Lyons Gaffaney, Cecilia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Building 56 ^*  (United States)

Author keywords

Cervical ripening; Labour induction; Misoprostol

Indexed keywords

MISOPROSTOL; OXYTOCIN; PHENOTHIAZINE; PROGESTERONE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; TERBUTALINE;

ABDOMINAL PAIN; ABORTION; ARTHROGRYPOSIS; BLADDER EXSTROPHY; CARDIOTOCOGRAPHY; CESAREAN SECTION; CHILL; CHORIOAMNIONITIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIARRHEA; DISORDERS OF ACID BASE BALANCE; DOSE RESPONSE; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG EXCRETION; DRUG FATALITY; DRUG FORMULATION; DRUG SAFETY; DRUG SYNTHESIS; FETUS DISTRESS; FETUS ELECTROCARDIOGRAPHY; FETUS HEART RATE; FEVER; GASTROINTESTINAL SYMPTOM; HEART RATE VARIABILITY; HOLOPROSENCEPHALY; HUMAN; HYDROCEPHALUS; HYPERTHERMIA; HYPOXEMIA; LABOR INDUCTION; LIMB DEFECT; LUTEAL INSUFFICIENCY; MATERNAL DISEASE; MATERNAL MORTALITY; MOEBIUS SYNDROME; MORBIDITY; NAUSEA; NEWBORN DISEASE; NEWBORN MORBIDITY; PATIENT MONITORING; PERINATAL DEATH; PHYSIOLOGY; PREMATURE FETUS MEMBRANE RUPTURE; REVIEW; RHABDOMYOLYSIS; RISK ASSESSMENT; SAFETY; SCAR; SHIVERING; SYSTEMIC DISEASE; TABLET; TACHYCARDIA; TERATOGENICITY; TOCOLYSIS; TREATMENT CONTRAINDICATION; URINARY EXCRETION; UTERINE CERVIX RIPENING; UTERINE HYPERTONIA; UTERUS CONTRACTILITY; UTERUS DISEASE; UTERUS HYPERSTIMULATION; UTERUS RUPTURE; UTERUS TACHYSYSTOLE; VASCULAR DISEASE; VOMITING;

ADMINISTRATION, INTRAVAGINAL; AMBULATORY CARE; CERVICAL RIPENING; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LABELING; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; PREGNANCY;

EID: 33746823371     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200609000-00021     Document Type: Review

References (84)

1. American College of Obstetricians and Gynecologists. Induction of Labor. ACOG Practice Bulletin Number 10. Washington DC: American College of Obstetricians and Gynecologists; 1999.
2. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2003. Natl Vital Stat Rep. 2005;54:1-116.
3. Red Book: Pharmacy's Fundamental Reference. 2005 edition. Montvale, NJ: Thomson Healthcare/Thomson PDR.
4. Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.
5. Foote EF, Lee DR, Karim A, et al. Disposition of misoprostol and its active metabolite in patients with normal and impaired renal function. J Clin Pharmacol. 1995;35:384-389.
6. Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332-336.
7. Bond GR, Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol. 1994;171:561-562.
8. Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275-280.
9. Aronsson A, Brydeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod. 2004;19:81-84.
10. Ramsey PS, Meyer L, Walkes BA, et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol. 2005;105:85-90.
11. Ramsey PS, Ogburn PL Jr, Harris DY, et al. Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labor induction. Am J Obstet Gynecol. 2000;182:1616-1619.
12. Gunalp S, Bildirici I. The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of labor. Acta Obstet Gynecol Scand. 2000;79:283-285.
13. Chandra S, Allen V, Lee W, et al. The effect of vaginal pH on labor induction with vaginal misoprostol. J Matern Fetal Neonatal Med. 2005;17:387-391.
14. Carlan SJ, Bouldin S, O'Brien WF. Extemporaneous preparation of misoprostol gel for cervical ripening: a randomized trial. Obstet Gynecol. 1997;90:911-915.
15. Ngai SW, To WK, Lao T, et al. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol. 1996;87:923-926.
16. Politz LB, Chez RA, Parsons MT, et al. The effect of a pill inserter on vaginal misoprostol dosing. J Matern Fetal Med. 2001;10:332-334.
17. Margulies M, Perez GC, Voto LS. Misoprostol to induce labor. Lancet. 1992;339:64.
18. Sanchez-Ramos L, Kaunitz AM, Del Valle GO, et al. Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynecol. 1993;81:332-336.
19. Kramer RL, Gilson GJ, Morrison DS, et al. A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy. Obstet Gynecol. 1997;89:387-391.
20. Sanchez-Ramos L, Chen AH, Kaunitz AM, et al. Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol. 1997;89:909-912.
21. Wing DA, Paul RH. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation. Am J Obstet Gynecol. 1998;179:94-99.
22. Bughalo A, Bique C, Machungo F, et al. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour. Gynecol Obstet Invest. 1995;39:252-256.
23. Fletcher HM, Mitchell S, Simeon D, et al. Intravaginal misoprostol as a cervical ripening agent. Br J Obstet Gynecol. 1993;100:641-644.
24. Srisomboon J, Tongsong T, Tosiri V. Preinduction cervical ripening with intravaginal prostaglandin E1 methyl analogue misoprostol: a randomized controlled trial. J Obstet Gynaecol Res. 1996;22:119-124.
25. Kadanli S, Kucukozkan T, Zor N, et al. Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy. Int J Gynecol Obstet. 1993;55:99-104.
26. Fletcher H, Mitchell S, Frederick J, et al. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol. 1994;83:244-247.
27. Varaklis K, Gumina R, Stubblefield PG. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstet Gynecol. 1995;86:541-544.
28. Wing DA, Jones MM, Rahall A, et al. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172:1804-1810.
29. Wing DA, Rahall A, Jones MM, et al. Misoprostol: an effective agent for cervical ripening and labor induction. Am J Obstet Gynecol. 1995;172:1811-1816.
30. Chuck FJ, Huffaker BJ. Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (Prepidil gel): randomized comparison. Am J Obstet Gynecol. 1995;173:1137-1142.
31. Mundle WR, Young DC. Vaginal misoprostol for induction of labor: a randomized controlled trial. Obstet Gynecol. 1996;88:521-525.
32. Wing DA, Ortiz-Omphroy G, Paul RH. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction. Am J Obstet Gynecol. 1997;177:612-618.
33. Buser D, Mora G, Arias F. A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices. Obstet Gynecol. 1997;89:581-585.
34. Surbek DV, Boesinger H, Hoesli I, et al. A double-blind comparison of the safety and efficacy of intravaginal misoprostol and prostaglandin E2 to induce labor. Am J Obstet Gynecol. 1997;177:1018-1023.
35. Gottschall DS, Borgida AF, Mihalek JJ, et al. A randomized clinical trial comparing misoprostol with prostaglandin E2 gel for preinduction cervical ripening. Am J Obstet Gynecol. 1997;177:1067-1070.
36. Sanchez-Ramos L, Peterson DE, Delke I, et al. Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial. Obstet Gynecol. 1998;91:401-405.
37. Magtibay PM, Ramin KD, Harris DY, et al. Misoprostol as a labor induction agent. J Matern Fetal Med. 1998;7:15-18.
38. Kolderup L, McLean L, Grullon K, et al. Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk. Am J Obstet Gynecol. 1999;180:1543-1550.
39. Danielian P, Porter B, Ferri N, et al. Misoprostol for induction of labor at term: a more effective agent than dinoprostone vaginal gel. Br J Obstet Gynaecol. 1999;106:793-797.
40. Nunes F, Rodrigues R, Meirinho M. Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor. Am J Obstet Gynecol. 1999;181:626-629.
41. Vengalil SR, Guinn DA, Olabi NF, et al. A randomized trial of misoprostol and extraamniotic saline infusion for cervical ripening and labor induction. Am J Obstet Gynecol. 1998;91:774-779.
42. Perry KG, Larmon JE, May WL, et al. Cervical ripening: a randomized comparison between intravaginal misoprostol and an intracervical balloon catheter combined with intravaginal dinoprostone. Am J Obstet Gynecol. 1998;178:1333-1340.
43. Chung JH, Huang WH, Rumney PJ, et al. A prospective randomized controlled trial that compared misoprostol, Foley catheter, and combination misoprostol-Foley catheter for labor induction. Am J Obstet Gynecol. 2003;189:1031-1035.
44. Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z.Misoprostol for induction of labour: a systematic review. Br J Obstet Gynaecol. 1999;106:798-803.
45. Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: a meta-analysis. Obstet Gynecol. 1997;89:633-642.
46. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. The Cochrane Database Syst Rev. 2003;CD000941. DOI:10.1002/14651858.CD000941.
47. Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: a systematic review of the literature. Clin Obstet Gynecol. 2000;43:475-488.
48. Boulvain M, Kelly A, Lohse C, et al. Mechanical methods for induction of labour. The Cochrane Database Syst Rev. 2001;CD001233. DOI:10.1002/14651858. CD001233.
49. Goldberg AB, Greenberg MB, Darney PD. Drug therapy: misoprostol and pregnancy. New Engl J Med. 2001;3444:38-47.
50. Farah LA, Sanchez-Ramos L, Rosa C, et al. Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction. Am J Obstet Gynecol. 1997;177:364-371.
51. Diro M, Adra A, Gilles JM, et al. A double-blinded randomized trial of two dose regimens of misoprostol for cervical ripening and labor induction. J Matern Fetal Med. 1999;8:114-118.
52. Srisomboon J, Singchai S. A comparison between 25 micrograms and 50 micrograms of intravaginal misoprostol for labor induction. J Med Assoc Thai. 1998;81:779-783.
53. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol. 1996;175:158-164.
54. Lokugamage AU, Forsyth SF, Sullivan KR, et al. Randomized trial in multiparous patients: investigating a single vs. two-dose regimen of intravaginal misoprostol for induction of labor. Acta Obstet Gynecol Scand. 2003;82:138-142.
55. American College of Obstetricians and Gynecologists. Induction of labor with misoprostol. ACOG Committee Opinion No. 228. Washington, DC: American College of Obstetricians and Gynecologists; November 1999.
56. American College of Obstetricians and Gynecologists. Response to Searle's Drug Warning on Misoprostol. ACOG Committee Opinion No. 248. Washington, DC: American College of Obstetricians and Gynecologists; December 2000.
57. American College of Obstetricians and Gynecologists. New U.S. Food and Drug Administration Labeling on Cytotec (Misoprostol) Use and Pregnancy. ACOG Committee Opinion No. 283. Washington, DC: American College of Obstetricians and Gynecologists; May 2003.
58. Castaneda CS, Izquierdo Puente JC, Leon Ochoa RA, et al. Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women. Am J Obstet Gynecol. 2005;193(3 Part 2):1071-1075.
59. da Graca Krupa F, Cecatti JG, de Castro Surita FG, et al. Misoprostol versus expectant management in premature rupture of membranes at term. BJOG. 2005;112:1284-1290.
60. Lin MG, Nuthalapaty FS, Carver AR, et al. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol. 2005;106:593-601.
61. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol. 1998;91:828-830.
62. Sciscione AC, Nguyen L, Manley JS, et al. Uterine rupture during preinduction cervical ripening with misoprostol in a patient with a previous cesarean delivery. Aust NZ J Obstet Gynecol. 1998;38:96-97.
63. Rageth JC, Juzi C, Grossenbacher H. Delivery after previous cesarean: a risk evaluation. Swiss working group of obstetric and gynecologic institutions. Obstet Gynecol. 1999;93:332-337.
64. Vause S, Macintosh M. Evidence based case report: use of prostaglandins to induce labour in women with a cesaerean section scar. BMJ. 1999;318:1056-1058.
65. Blanchette H, Mayak S, Erasmus S. Comparison of the safety and efficacy of intravaginal misoprostol (prostaglandin E1) with those of dinoprostone (prostaglandin E2) for cervical ripening and induction of labor in a community hospital. Am J Obstet Gynecol. 1999;180:1551-1559.
66. Plaut MM, Schwartz ML, Lubarsky SL. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section. Am J Obstet Gynecol. 1999;180:1535-1542.
67. Cunha M, Bugalho A, Bique C, et al. Induction of labor by vaginal misoprostol in patients with previous cesarean delivery. Acta Obstet Gynecol Scand. 1999;78:653-654.
68. Hill DA, Chez RA, Quinlan J, et al. Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening. J Reprod Med. 2000;45:823-926.
69. Sanchez-Ramos L, Gaudier FL, Kaunitz AM. Cervical ripening and labor induction after previous cesarean delivery. Clin Obstet Gynecol. 2000;43:513-523.
70. Choy-Hee I, Raynor BD. Misoprostol induction of labor among women with history of cesarean delivery. Am J Obstet Gynecol. 2001;184:1115-1117.
71. Aslan H, Unlu E, Agar M, et al. Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery. Eur J Obstet Gynecol Reprod Biol. 2004;113:45-48.
72. Bennett BB. Uterine rupture during induction of labor at term with intravaginal misoprostol. Obstet Gynecol. 1997;89:832-833.
73. Khabbaz AY, Usta IM, El-Hajj MI, et al. Report of an unscarred uterus with misoprostol induction: case report and review of the literature. J Matern Fetal Med. 2001;10:141-145.
74. Thomas A, Jophy R, Maskhar A, et al. Uterine rupture in a primigravida with misoprostol used for induction of labour. BJOG. 2003;110:217-218.
75. Stitely ML, Browning J, Fowler M, et al. Outpatient cervical ripening with intravaginal misoprostol. Obstet Gynecol. 2000;96:325-326.
76. Incerpi MH, Fassett MJ, Kjos SL, et al. Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol. 2001;185:916-919.
77. Oboro VO, Tabowei TO. Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post-term pregnancy. Acta Obstet Gynecol Scand. 2005;84:628-631.
78. Meyer M, Pflum J, Howard D. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Obstet Gynecol. 2005;105:466-472.
79. Rayburn WF, Farmer KC. Off-label prescribing during pregnancy. Obstet Gynecol Clin N Am. 1997;24:471-478.
80. Use of approved drugs for unlabeled indications. FDA Bull. 1982;12:4.
81. Pastuszak AL, Schuler L, Speak-Martins CE, et al. Use of misoprostol during pregnancy and Mobius' syndrome in infants. New Engl J Med. 1998;338:1881-1885.
82. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet. 1998;351:1624-1627.
83. Vargas FR, Schuler-Faccini L, Brunoni D, et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet. 2000;95:302-306.
84. Orioli IM, Castilla EE. Epidemiological assessment of misoprostol teratogenicity. BJOG. 2000;107:519-523.